Cargando…
Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective
Due to excess energy intake and a sedentary lifestyle, the prevalence of obesity is rising steadily and has emerged as a global public health problem. Adipose tissue undergoes structural remodeling and dysfunction in the obese state. Secreted proteins derived from the liver, also termed as hepatokin...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308077/ https://www.ncbi.nlm.nih.gov/pubmed/37396511 http://dx.doi.org/10.1016/j.gendis.2021.12.011 |
_version_ | 1785066171090862080 |
---|---|
author | Zhang, Yao Wang, Yibing Liu, Junli |
author_facet | Zhang, Yao Wang, Yibing Liu, Junli |
author_sort | Zhang, Yao |
collection | PubMed |
description | Due to excess energy intake and a sedentary lifestyle, the prevalence of obesity is rising steadily and has emerged as a global public health problem. Adipose tissue undergoes structural remodeling and dysfunction in the obese state. Secreted proteins derived from the liver, also termed as hepatokines, exert multiple effects on adipose tissue remodeling and the development of obesity, and has drawn extensive attention for their therapeutic potential in the treatment of obesity and related diseases. Several novel hepatokines and their functions on systemic metabolism have been interrogated recently as well. The drug development programs targeting hepatokines also have shown inspiring benefits in obesity treatment. In this review, we outline how adipose tissue changes during obesity. Then, we summarize and critically analyze the novel findings on the effects of metabolic “beneficial” and metabolic “harmful” hepatokines to adipose tissue. We also discuss the in-depth molecular mechanism that hepatokines may mediate the liver-adipose tissue crosstalk, the novel technologies targeting hepatokines and their receptors in vivo to explore their functions, and the potential application of these interventions in clinical practice. |
format | Online Article Text |
id | pubmed-10308077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Chongqing Medical University |
record_format | MEDLINE/PubMed |
spelling | pubmed-103080772023-06-30 Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective Zhang, Yao Wang, Yibing Liu, Junli Genes Dis Review Article Due to excess energy intake and a sedentary lifestyle, the prevalence of obesity is rising steadily and has emerged as a global public health problem. Adipose tissue undergoes structural remodeling and dysfunction in the obese state. Secreted proteins derived from the liver, also termed as hepatokines, exert multiple effects on adipose tissue remodeling and the development of obesity, and has drawn extensive attention for their therapeutic potential in the treatment of obesity and related diseases. Several novel hepatokines and their functions on systemic metabolism have been interrogated recently as well. The drug development programs targeting hepatokines also have shown inspiring benefits in obesity treatment. In this review, we outline how adipose tissue changes during obesity. Then, we summarize and critically analyze the novel findings on the effects of metabolic “beneficial” and metabolic “harmful” hepatokines to adipose tissue. We also discuss the in-depth molecular mechanism that hepatokines may mediate the liver-adipose tissue crosstalk, the novel technologies targeting hepatokines and their receptors in vivo to explore their functions, and the potential application of these interventions in clinical practice. Chongqing Medical University 2022-02-02 /pmc/articles/PMC10308077/ /pubmed/37396511 http://dx.doi.org/10.1016/j.gendis.2021.12.011 Text en © 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Zhang, Yao Wang, Yibing Liu, Junli Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective |
title | Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective |
title_full | Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective |
title_fullStr | Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective |
title_full_unstemmed | Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective |
title_short | Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective |
title_sort | friend or foe for obesity: how hepatokines remodel adipose tissues and translational perspective |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308077/ https://www.ncbi.nlm.nih.gov/pubmed/37396511 http://dx.doi.org/10.1016/j.gendis.2021.12.011 |
work_keys_str_mv | AT zhangyao friendorfoeforobesityhowhepatokinesremodeladiposetissuesandtranslationalperspective AT wangyibing friendorfoeforobesityhowhepatokinesremodeladiposetissuesandtranslationalperspective AT liujunli friendorfoeforobesityhowhepatokinesremodeladiposetissuesandtranslationalperspective |